“TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS” (2022) JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(3), pp. 92–101. doi:10.53366/jimki.v9i3.488.